세계의 종양학 분석 솔루션용 AI 시장 보고서(2025년)

AI in oncology for analytical solutions involves the utilization of artificial intelligence (AI) technology within the oncology field to develop advanced analytical solutions for cancer research, diagnosis, and treatment. This technology aids healthcare professionals in making data-driven decisions, enhancing diagnostic accuracy, and customizing treatment plans.

The primary components in AI in oncology for analytical solutions include data licensing services, software solutions, analytics, and other related elements. Data licensing entails the process of granting or obtaining legal permission to utilize and access data, typically through a contractual agreement between the data provider (licensor) and the data user (licensee). These solutions encompass various treatment types such as chemotherapy, radiotherapy, immunotherapy, and others, catering to a wide array of cancer types including breast cancer, lung cancer, prostate cancer, colorectal cancer, brain tumors, kidney cancer, non-Hodgkin lymphoma, and bladder cancer.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The AI in oncology for analytical solutions market research report is one of a series of new reports from The Business Research Company that provides AI in oncology for analytical solutions market statistics, including AI in oncology for analytical solutions industry global market size, regional shares, competitors with a AI in oncology for analytical solutions market share, detailed AI in oncology for analytical solutions market segments, market trends and opportunities, and any further data you may need to thrive in the AI in oncology for analytical solutions industry. This AI in oncology for analytical solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ai in oncology for analytical solutions market size has grown exponentially in recent years. It will grow from $1.07 billion in 2024 to $1.44 billion in 2025 at a compound annual growth rate (CAGR) of 34.4%. The growth in the historic period can be attributed to increasing healthcare data availability, rising awareness and acceptance, advancements in machine learning algorithms, government initiatives and funding, clinical acceptance.

The ai in oncology for analytical solutions market size is expected to see exponential growth in the next few years. It will grow to $4.67 billion in 2029 at a compound annual growth rate (CAGR) of 34.2%. The growth in the forecast period can be attributed to rising demand for personalized medicine, increasing healthcare awareness, integration of multi-omics data, regulatory refinement, telemedicine and remote diagnostics. Major trends in the forecast period include collaborations and partnerships, continuous technological advancements, industry collaborations, research and development initiatives, advancements in technology.

The forecast of 34.2% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. cancer centers by driving up the cost of Artificial intelligence(AI)-based tumor registry analytics and treatment optimization algorithms sourced from France and Singapore, exacerbating value-based care implementation costs and delaying personalized therapy decisions. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of cancer is expected to drive the expansion of the AI in oncology for analytical solutions market. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells. AI in oncology for analytical solutions plays a significant role in cancer care by enabling personalized treatment, early detection, and improved patient outcomes through its capacity to process large volumes of complex data quickly and efficiently. For example, in May 2024, the National Cancer Institute, a US-based government agency, projected that in 2024, approximately 2 million new cancer cases would be diagnosed in the U.S., with over 611,000 cancer-related deaths. By 2040, new cancer cases globally are expected to rise to 29.9 million, with cancer-related deaths reaching 15.3 million. As a result, the increasing prevalence of cancer is driving the growth of AI in oncology for analytical solutions.

Prominent companies in the AI in oncology for analytical solutions market are focusing on advancing AI technologies, including the development of new real-world data platforms to accelerate cancer research and enhance generative AI models in oncology. A real-world data platform integrates and manages observational data from diverse sources outside of conventional clinical research settings, such as electronic health records, health insurance claims, patient surveys, and disease registries. For instance, in October 2023, the Central Ohio Transit Authority in the US launched Vista, a new real-world data platform designed to expedite cancer research and enhance generative AI models in oncology. Vista integrates multiple databases, including the data portal database and the genomic database, to provide a comprehensive and standardized approach to managing cancer research data. Additionally, Vista is expected to facilitate data sharing, enhance data quality, and support various applications in oncology and other healthcare domains.

In December 2023, ConcertAI, an India-based medical research developer, acquired CancerLinQ, a US-based cancer treatment company specializing in AI-based data and analytics, aiming to establish the leading healthcare learning and research network in oncology. This acquisition seeks to provide members with upgraded quality reporting, industry-leading real-world data, and AI-powered solutions to accelerate clinical trials.

Major companies operating in the AI in oncology for analytical solutions market report are IBM Watson Health, NVIDIA Corporation, Siemens Healthineers, GE Healthcare, Tempus, DeepMind Health, Paige.AI, PathAI, Aidoc, Nucleai, HeartFlow, OWKIN, SOPHiA Genetics, Imagen Technologies, Butterfly Network, Atomwise, Enlitic, Inspirata, 3Scan, Zebra Medical Vision, Ibex Medical Analytics, Vuno Inc., Proscia, Google Health, Huiying Medical

North America was the largest region in the AI In oncology for analytical solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the AI in oncology for analytical solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the AI in oncology for analytical solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The AI in oncology for analytical solutions market consists of revenues earned by entities by providing services such as consulting services, implementation services, training services, medical imaging analysis services, genomic data interpretation services, and drug discovery and development solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in oncology for analytical solutions market also includes sales of AI-powered imaging tools, drug discovery and development devices, and recurrence monitoring systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

AI In Oncology For Analytical Solutions Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ai in oncology for analytical solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ai in oncology for analytical solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ai in oncology for analytical solutions market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Component: Data Licensing Services; Software Solutions; Analytics and Other Services
• 2) By Treatment Type: Chemotherapy; Radiotherapy; Immunotherapy; Other Treatments
• 3) By Cancer Type: Breast Cancer; Lung Cancer; Prostate Cancer; Colorectal Cancer; Brain Tumor; Kidney Cancer; Non-Hodgkin Lymphoma; Bladder Cancer
• Subsegments:
• 1) By Data Licensing Services: Oncology Data Licensing; Genomic Data Licensing
• 2) By Software Solutions: AI-Based Imaging Software; Diagnostic Software; Clinical Decision Support Software
• 3) By Analytics And Other Services: Predictive Analytics Services; AI Training And Support Services; Data Analysis Services
• Companies Mentioned: IBM Watson Health; NVIDIA Corporation; Siemens Healthineers; GE Healthcare; Tempus; DeepMind Health; Paige.AI; PathAI; Aidoc; Nucleai; HeartFlow; OWKIN; SOPHiA Genetics; Imagen Technologies; Butterfly Network; Atomwise; Enlitic; Inspirata; 3Scan; Zebra Medical Vision; Ibex Medical Analytics; Vuno Inc.; Proscia; Google Health; Huiying Medical
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. AI In Oncology For Analytical Solutions Market Characteristics

3. AI In Oncology For Analytical Solutions Market Trends And Strategies

4. AI In Oncology For Analytical Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global AI In Oncology For Analytical Solutions Growth Analysis And Strategic Analysis Framework

• 5.1. Global AI In Oncology For Analytical Solutions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global AI In Oncology For Analytical Solutions Market Growth Rate Analysis
• 5.4. Global AI In Oncology For Analytical Solutions Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global AI In Oncology For Analytical Solutions Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global AI In Oncology For Analytical Solutions Total Addressable Market (TAM)

6. AI In Oncology For Analytical Solutions Market Segmentation

• 6.1. Global AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Data Licensing Services
• Software Solutions
• Analytics and Other Services
• 6.2. Global AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemotherapy
• Radiotherapy
• Immunotherapy
• Other Treatments
• 6.3. Global AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Colorectal Cancer
• Brain Tumor
• Kidney Cancer
• Non-Hodgkin Lymphoma
• Bladder Cancer
• 6.4. Global AI In Oncology For Analytical Solutions Market, Sub-Segmentation Of Data Licensing Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology Data Licensing
• Genomic Data Licensing
• 6.5. Global AI In Oncology For Analytical Solutions Market, Sub-Segmentation Of Software Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• AI-Based Imaging Software
• Diagnostic Software
• Clinical Decision Support Software
• 6.6. Global AI In Oncology For Analytical Solutions Market, Sub-Segmentation Of Analytics And Other Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Predictive Analytics Services
• AI Training And Support Services
• Data Analysis Services

7. AI In Oncology For Analytical Solutions Market Regional And Country Analysis

• 7.1. Global AI In Oncology For Analytical Solutions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global AI In Oncology For Analytical Solutions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific AI In Oncology For Analytical Solutions Market

• 8.1. Asia-Pacific AI In Oncology For Analytical Solutions Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China AI In Oncology For Analytical Solutions Market

• 9.1. China AI In Oncology For Analytical Solutions Market Overview
• 9.2. China AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India AI In Oncology For Analytical Solutions Market

• 10.1. India AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan AI In Oncology For Analytical Solutions Market

• 11.1. Japan AI In Oncology For Analytical Solutions Market Overview
• 11.2. Japan AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia AI In Oncology For Analytical Solutions Market

• 12.1. Australia AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia AI In Oncology For Analytical Solutions Market

• 13.1. Indonesia AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea AI In Oncology For Analytical Solutions Market

• 14.1. South Korea AI In Oncology For Analytical Solutions Market Overview
• 14.2. South Korea AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe AI In Oncology For Analytical Solutions Market

• 15.1. Western Europe AI In Oncology For Analytical Solutions Market Overview
• 15.2. Western Europe AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK AI In Oncology For Analytical Solutions Market

• 16.1. UK AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany AI In Oncology For Analytical Solutions Market

• 17.1. Germany AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France AI In Oncology For Analytical Solutions Market

• 18.1. France AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy AI In Oncology For Analytical Solutions Market

• 19.1. Italy AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain AI In Oncology For Analytical Solutions Market

• 20.1. Spain AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe AI In Oncology For Analytical Solutions Market

• 21.1. Eastern Europe AI In Oncology For Analytical Solutions Market Overview
• 21.2. Eastern Europe AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia AI In Oncology For Analytical Solutions Market

• 22.1. Russia AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America AI In Oncology For Analytical Solutions Market

• 23.1. North America AI In Oncology For Analytical Solutions Market Overview
• 23.2. North America AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA AI In Oncology For Analytical Solutions Market

• 24.1. USA AI In Oncology For Analytical Solutions Market Overview
• 24.2. USA AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada AI In Oncology For Analytical Solutions Market

• 25.1. Canada AI In Oncology For Analytical Solutions Market Overview
• 25.2. Canada AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America AI In Oncology For Analytical Solutions Market

• 26.1. South America AI In Oncology For Analytical Solutions Market Overview
• 26.2. South America AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil AI In Oncology For Analytical Solutions Market

• 27.1. Brazil AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East AI In Oncology For Analytical Solutions Market

• 28.1. Middle East AI In Oncology For Analytical Solutions Market Overview
• 28.2. Middle East AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa AI In Oncology For Analytical Solutions Market

• 29.1. Africa AI In Oncology For Analytical Solutions Market Overview
• 29.2. Africa AI In Oncology For Analytical Solutions Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa AI In Oncology For Analytical Solutions Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa AI In Oncology For Analytical Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. AI In Oncology For Analytical Solutions Market Competitive Landscape And Company Profiles

• 30.1. AI In Oncology For Analytical Solutions Market Competitive Landscape
• 30.2. AI In Oncology For Analytical Solutions Market Company Profiles
  • 30.2.1. IBM Watson Health Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. NVIDIA Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. GE Healthcare Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Tempus Overview, Products and Services, Strategy and Financial Analysis

31. AI In Oncology For Analytical Solutions Market Other Major And Innovative Companies

• 31.1. DeepMind Health
• 31.2. Paige.AI
• 31.3. PathAI
• 31.4. Aidoc
• 31.5. Nucleai
• 31.6. HeartFlow
• 31.7. OWKIN
• 31.8. SOPHiA Genetics
• 31.9. Imagen Technologies
• 31.10. Butterfly Network
• 31.11. Atomwise
• 31.12. Enlitic
• 31.13. Inspirata
• 31.14. 3Scan
• 31.15. Zebra Medical Vision

32. Global AI In Oncology For Analytical Solutions Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The AI In Oncology For Analytical Solutions Market

34. Recent Developments In The AI In Oncology For Analytical Solutions Market

35. AI In Oncology For Analytical Solutions Market High Potential Countries, Segments and Strategies

• 35.1 AI In Oncology For Analytical Solutions Market In 2029 - Countries Offering Most New Opportunities
• 35.2 AI In Oncology For Analytical Solutions Market In 2029 - Segments Offering Most New Opportunities
• 35.3 AI In Oncology For Analytical Solutions Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer